EHE 360 2026 GLOBAL CONFERENCE

APRIL 30 - May 1, 2026

Advancing Research. Building Knowledge. Strengthening Community.

The EHE 360 Global Conference is the largest annual gathering dedicated entirely to epithelioid hemangioendothelioma (EHE). Each year, patients, caregivers, clinicians, and researchers from around the world come together to learn, connect, and move research forward.

Virtual and free to attend, EHE 360 is designed to give people diagnosed with EHE and their families direct access to the experts shaping the future of care. Through live presentations and interactive discussions, participants:

  • Learn about the biology of EHE and how it impacts diagnosis and treatment
  • Hear updates on emerging research and potential therapies
  • Gain insight into clinical care and quality of life considerations
  • Ask questions directly to leading researchers and clinicians

The knowledge shared at EHE 360 helps advance research, inform clinical care, and ensure the patient voice remains central to progress in EHE. When patients, caregivers, and experts share and learn together, progress moves faster, and the entire EHE community benefits.

New this year: EHE 360 Social Hour
Created in response to community feedback, EHE 360 Social Hour gives registered attendees extra time to connect informally after the conference. Following the close of EHE 360 Day 2, at 1:00 pm ET, attendees are invited to stay on Zoom for open conversation and connection.

research-icon

Thursday, April 30th | 10:00 am - 1:00 pm ET EHE Scientific Symposium

Presentations will focus on science aimed at identifying effective therapies. Attendees will leave with a better understanding of how research translates into effective treatments in the clinic.

 
Denise Robinson

Denise Robinson, Executive Director

EHE Foundation

Welcome & Introduction

Tom Wei-Wu Chen, MD, PhD

Tom Wei-Wu Chen, MD, PhD

National Taiwan University Hospital

Keynote: Building Momentum in Research to Improve Outcomes in EHE

Session 1

Novel Approaches to Target EHE Fusions

Professor Kieran Harvey

Kieran Harvey, Professor

Peter MacCallum Cancer Centre, Australia

Real Time Investigation of EHE Fusion Protein Behaviour

Dr. Jens Bauer

Jens Bauer, PhD

University Hospital Tubingen, Germany

Immunopeptidome-guided Target Discovery for T-cell Based Immunotherapy

Session 2

Exploring Druggable Pathways to Treat EHE

John Lamar

John Lamar, PhD

Albany Medical College

Uncovering New Therapies and Clinical Biomarkers in Epithelioid Hemangioendothelioma

Gillian DeWane, PhD

Gillian DeWane, PhD

University of Iowa

Combination Therapy Approaches Targeting Genomic and Signal Transduction Vulnerabilities in EHE

Ajaybabu Pobbati

Ajaybabu Pobbati, PhD

Cleveland Clinic

Targeting the Oncogenic Transcriptional Complex in EHE

Session 3

Partnering to Accelerate Discovery in EHE

Catherine Weadick, MB BCh BAO, MSc

Catherine Weadick, MB BCh BAO, MSc

The Princess Margaret Hospital

CanSaRCC & PRO_CARE EHE: Insights from Canadian Research

Taran Gujral, PhD

Taran Gujral, PhD

Fred Hutch Cancer Center

TRACER: Breaking Barriers in Rare Cancer

Kristianne Oristian, PhD

Kristianne Oristian, PhD

EHE Foundation

Opportunities to Drive Research Forward - Be the Key

clinical care

Friday, May 1st | 10:00 am - 1:00 pm ET EHE Clinical Care Summit

Presentations will focus on the clinical management of EHE, including the popular Ask the Expert panel. Researchers will also share insights from patient-reported EHE experiences.

 
Session 1

Exploring EHE Diagnosis & Management

Brian Rubin

Brian Rubin, MD, PhD

Cleveland Clinic

Understanding Your EHE Diagnosis

Nam Quoc Bui, MD

Nam Quoc Bui, MD

Stanford Cancer Institute

Management of EHE: A Case Based Discussion

Shree Venkat, MD

Shree Venkat, MD

Moffitt Cancer Center

Management of EHE: Role of Interventional Radiology

Session 2

Clinical Trials for EHE

Michael Wagner, MD

Michael Wagner, MD

Dana-Farber Cancer Institute

SARC046: A Phase II Trial of Nab-Sirolimus in Patients With Progressing or Symptomatic EHE

Antoine Italiano, MD, PhD

Institut Bergonié, France

Early Insights from ODM-212, a TEAD Inhibitor, in Patients with EHE

Session 3

Integrative Medicine & Supportive Care

Kerri Winters-Stone, PhD

Kerri Winters-Stone, PhD

Oregon Health & Science University

The Importance of Exercise for People with Cancer

Tamara Vesel, MD

Tamara Vesel, MD

Tufts Medicine

Living Well With EHE: Finding Support in a Time of Uncertainty

Ask the Expert Panel

Greg Cote, MD, PhD

Gregory Cote, MD, PhD

Mass General Brigham Cancer Institute

Ask the Expert

Thierry Alcindor, MD, MSc

Thierry Alcindor, MD, MSc

Dana-Farber Cancer Institute

Ask the Expert

Melissa A. Burgess, MD

Melissa A. Burgess, MD

UPMC Hillman Cancer Center

Ask the Expert

social-icon

Friday, May 1st | 1:00 - 2:00 pm ET EHE 360 Social Hour

Created in response to community feedback, EHE 360 Social Hour gives registered attendees extra time to connect informally after the conference. Following the final presentation of EHE 360 Day 2 at 1:00 pm ET, registered attendees are invited to stay on Zoom for open conversation and connection.

Thanks to our generous sponsors!

GOLD
SILVER

Past Annual Conferences

2025

EHE 360 2025 GLOBAL PATIENT CONFERENCE

CONNECT. EXPLORE. LEARN.

April 10-11, 2025

2024

EHE 360

EMPOWERING  PATIENTS
THROUGH  EDUCATION

2024 GLOBAL PATIENT CONFERENCE

 
2023

EHE 360

EMPOWERING PATIENTS

2023 GLOBAL PATIENT CONFERENCE

2022

2022 EHE 360 INTERNATIONAL CONFERENCE

January 28: Scientific Symposium 
January 29: Global Patient Conference